Plasma Proteomics Reveals Distinct Signatures in Occult and Microfilaremic Loa loa Infections
Open Access
- 17 July 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 232 (3) , e383-e392
Abstract
Background: Loiasis, caused by the filarial nematode Loa loa, imposes a significant disease burden in endemic regions in West and Central Africa. Manifestations include adult worms in soft tissue (e.g., the conjunctiva of the eye) and microfilaria in peripheral blood, with clinical presentations ranging from asymptomatic infections to life-threatening organ involvement. Diagnosis remains challenging due to variable microfilaria counts, frequent amicrofilaremic occult infections, and unreliable serological tests. The untargeted plasma proteome reflects broad (patho-)physiological responses, providing valuable insights into the host and disease. Methods: Applying high-throughput plasma proteomics, we investigated the host responses of 274 patients with different L. loa disease states, including occult loiasis (n = 148), microfilaremia (n = 42), or both (n = 84), compared to 136 L. loa–negative controls. Differentially abundant proteins between L. loa–infected individuals and negative controls were validated using targeted proteomics. Results: Five proteins (IGHG3, IGHG4, ACTBL2, LCP1, and IGLV9-49) were elevated in infected individuals compared to healthy controls. IGHG3, IGHG4, ACTB, and LCP1 increased from L. loa negative over individuals with history of eye worm migration to microfilaremic patients, indicating a comparatively pronounced proteomic host response to microfilaria in the blood. Sixty-three proteins differed depending on self-reported symptoms. The proteomic signatures enabled accurate classification of individuals with occult loiasis (area under the receiver operating characteristic curve [AUROC] = 0.73) and microfilaremia (AUROC = 0.84) by a random forest machine learning model. Conclusions: Overall, infection with Loa loa alters the host plasma proteome, exhibiting distinct host responses in different infection states and allowing for molecular disease classification of this highly neglected parasitic disease.Keywords
Funding Information
- Federal Ministry of Science, Research and Economy of Austria
- European and Developing Countries Clinical Trials Partnership 2 programme
- European Union (A12/B-2)
- German Center for Infection Research (TI 07.001)
- German Federal Ministry of Education and Research (031L0286B)
This publication has 32 references indexed in Scilit:
- The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasisThe Lancet Infectious Diseases, 2023
- A call for loiasis to be added to the WHO list of neglected tropical diseasesThe Lancet Infectious Diseases, 2022
- World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2021
- A time-resolved proteomic and prognostic map of COVID-19Cell Systems, 2021
- Burden of disease in Gabon caused by loiasis: a cross-sectional surveyThe Lancet Infectious Diseases, 2020
- Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 InfectionCell Systems, 2020
- Role of IgG3 in Infectious DiseasesTrends in Immunology, 2019
- Excess mortality associated with loiasis: a retrospective population-based cohort studyThe Lancet Infectious Diseases, 2017
- Loa loa—does it deserve to be neglected?The Lancet Infectious Diseases, 2014
- Allergen-specific IgE and IgG4 are markers of resistance and susceptibility in a human intestinal nematode infectionMicrobes and Infection, 2005